All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
During the 13th European Lupus Meeting, the Lupus Hub was pleased to speak to Jill Buyon, New York University, New York, US. We asked, What do healthcare professionals need to know about neonatal lupus?
What do HCPs need to know about neonatal lupus?
Jill Buyon opens by discussing the incidence of anti-Ro and anti-La antibodies in pregnancy and the likelihood of this resulting in neonatal lupus, with a focus on congenital heart block as an indicator. Buyon goes on to outline the importance of early detection and tailored treatment plans depending on the nature of the cardiovascular presentation and concludes by highlighting the potential for future at-home monitoring techniques.
HCQ dose and risk of hospitalization in patients with SLE
During the ACR Convergence 2022, Jacquelyn Nestor discussed whether <5 mg/kg/day HCQ dosing leads to an increase in flares requiring hospitalization in patients with SLE when compared with...
Association between glucocorticoids and chronic damage accrual in patients with SLE
Here, we summarize a study by Sada et al., recently published in Lupus Science & Medicine, investigating the factors associated with a GC-free treatment status in SLE...
Subscribe to get the best content related to lupus delivered to your inbox